Thanks for the feature @leadindicator1 . Apple: Spotify: Youtube:

Thanks @KVUE for visiting our Austin office to meet with @Matt_R_Angle and Stephen Ryu.

Thanks for having us @BciSociety! What a stellar week. Based on the pre-clinical results, the Connexus BCI:.- Is safe and yields information-rich neural signals. - Demonstrated a high channel yield and stable signal quality with sustained decoding performance at almost 3 years.

RT @umichneuro: “What we're working on right now may eventually allow for either replacement or restoration of motor or speech function for….

We are headed to @BciSociety!.Here’s your chance to learn more about the #BCI with the highest data rates that have ever been reported. - Stop by our booth to learn more about Connexus & get tatted (temporary that is). - Join our Lunch Insights presentation.- Check out our poster

🎙️ Paradromics CEO @Matt_R_Angle joined @rjlumba on Great Entrepreneurs. "#BCI companies have the potential to be more like the Intels and NVIDIAs of this next generation, where they are pipelining innovations to products and pushing the frontier.".

We’re proud to share that Dr. Stephen Ryu has joined Paradromics as our Chief Medical Officer!. Dr. Ryu, a board-certified neurosurgeon, is the Chair of Neurosurgery at the Palo Alto Medical Foundation, and holds adjunct faculty appointments at @Stanford.

"This is the future I’m betting on—a future where AI doesn’t just run software but runs the world. Austin is uniquely equipped to lead this charge.". Thanks for the feature @amirhusain_tx @Forbes! .

How did chicken sexing come up in a podcast about the #BCI space?. Don’t miss a humor-filled & insightful discussion between @Matt_R_Angle and @VivekGaripalli about Paradromics and the future of the #neurotech field!

We are excited to announce @DrDavidBrandman as study principal investigator and Daniel Rubin, M.D., Ph.D. as investigator for the upcoming Connexus BCI Clinical Study.

We are thrilled to announce an investment by @NEOM Investment Fund (NIF) in Paradromics. Paradromics and NEOM are aligned on an expansive vision of a future with impactful BCI-based therapies.

We’re excited to be a part of @WIRED's upcoming event, The Big Interview, showcasing the people, platforms, technologies, and ideas that are shaping our shared future.

🧠🎙️Neurotech Pub is back this week! Our latest episode features @AmitEtkin from @AltoNeuro, @MaryamShanechi from USC, and Prasad Shirvalkar @ShirvalkarLab from UC San Francisco.

What do neuroscience experts and industry leaders talk about over beers–or in some cases–non-alcoholic beverages?. Find out in our latest episode of #NeurotechPub! . #neurotech

In this article, our Chief Scientific Officer Vikash Gilja makes the case for why Paradromics devices are designed to last for over a decade and provide “as long a gap between successive neurosurgeries as possible.".

🚨Listen to the latest #NeurotechPub episode with host @Matt_R_Angle and neurotech leaders @mljmljmlj from Openwater, @RyanMField from @KernelCo, and @SumnerLN from @ForestNeurotech. Tune in for a mind-blowing discussion! 🧠🎙️. #neurotech

Learn about how our Connexus® Direct Data Interface will enable people who have lost the ability to speak and beyond.

Thanks @ashleycapoot! ! Great article featuring Paradromics on @CNBC's Healthy Returns.

Thank you for speaking with us @jchatterleyCNN and @CNN!.

🚨 Don't miss the season 3 premiere of Neurotech Pub! Join @Matt_R_Angle, & leading experts @JTRobinsonLab from @motifneuro, Grayson Zulauf from Resonant Link, & Alexander Yeh from @neusperamedical as they discuss developments in wireless power tech for implantable devices.